According to the Asia Pacific Metabolic Testing Market Forecast Report, the market is valued at USD 79.94 million in 2019 and estimated to grow at a CAGR of 7.2%, to reach USD 112.89 million by 2024 during the forecast period 2019-2024. The Asia Pacific Metabolic Testing market is developing at an exceptionally quick pace.
Metabolism is a chemical reaction and physical process that involves maintenance of the living state, such as breathing, blood circulation, contraction of muscles, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, and functioning of brain and nerves of the organism. It is a pathway that begins with a sequence of chemical reactions with a specific molecule and ends with a product with the help of a specific enzyme. Enzymes are vital to metabolism as they allow the organism to drive reactions for the required energy. It is divided into two categories, i.e. catabolism and anabolism. A comprehensive metabolic panel is a blood test that measures your sugar (glucose) level, electrolyte and fluid balance, kidney function, and liver function.
The significant driver is the rising prevalence of lifestyle-based diseases coupled with the increasing geriatric population with high susceptibility towards developing chronic diseases such as cancer and kidney disorders. Also, the surge in technological advancements such as the introduction of digital metabolic rate testing equipment and rapidly increasing healthcare expenditure levels in developed and developing nations is boosting the industry.
This research report segmented and sub-segmented into the following categories:
The Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia, and South East Asia. China and India are likely to increase the market because of a huge population. Also, Asia Pacific is the largest growing segment.
The Top companies leading in the APAC Metabolic Testing Market profiled in the report are Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 CPET Systems
5.1.3 Metabolic Carts
5.1.4 ECG and EKG Systems
5.1.5 Body Composition Analyzers
5.1.6 Software
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 VO2 Max Analysis
5.2.3 RMR Analysis
5.2.4 Body Composition Analysis
5.2.5 Y-o-Y Growth Analysis, By Technology
5.2.6 Market Attractiveness Analysis, By Technology
5.2.7 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Lifestyle Diseases
5.3.3 Critical Care
5.3.4 Human Performance Testing
5.3.5 Dysmetabolic Syndrome X
5.3.6 Metabolic Disorders
5.3.7 Other Applications
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Laboratories
5.4.4 Sports Training Centers
5.4.5 GYMS
5.4.6 Other End Users
5.4.7 Y-o-Y Growth Analysis, By End User
5.4.8 Market Attractiveness Analysis, By End User
5.4.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Parvo Medics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Microlife Medical Home Solutions, Inc.
8.3 Korr Medical Technologies, Inc.
8.4 Cosmed
8.5 Cortex Biophysik GMBH
8.6 AEI Technologies, Inc.
8.7 OSI Systems, Inc.
8.8 MGC Diagnostics Corporation
8.9 Geratherm Medical AG
8.10 General Electric Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
